Back to Agenda
OVERVIEW OF CHANGING THE REGULATORY FRAMEWORK FOR COMBINATION PRODUCTS, MDD AND IVD
Session Chair(s)
Cordula Landgraf, RPh
Head of Networking
Swissmedic, Switzerland
Speaker(s)
Overview of Latest Development on the Proposed Revision of Medtech Legislation and Impact on Regulatory Framework for Combination Products
Shayesteh Fürst-Ladani, MBA, MS
SFL Regulatory Affairs & Scientific Communication, Switzerland
CEO
Regulator View of European Legislation for Combination Products
Waldo Weijers, PharmD
Medicines Evaluation Board, Netherlands
Secretary / Coordinator Consultation Procedures
Notified Body View on Revision of European Medtech Law Impacting Combination Products
Theresa Jeary, MSc
Lloyds Register Quality Assurance (LRQA), United Kingdom
Head of Notified Body
Have an account?